USPTO serial 79137789
MEDIX BIOCHEMICA
Reviewed by CopyMark Law Group
Reg. 4594982Status 708Registered
- Filing date
- Status date
- Registration date
- Sep 2, 2014
- Examiner
- REINHART, MEGHAN M
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MEDIX BIOCHEMICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roger H. Bora
Roger H. Bora Thompson Hine LLP10050 Innovation Drive, Suite 400Miamisburg, OH 45342-4934United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for medical research; reagent medium for medical research | ACTIVE | — |
| 005 | Diagnostic preparations for medical use; reagent medium for medical purposes | ACTIVE | — |
| 010 | [ Medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for medical use, namely, detectors and analyzers for use in in vitro diagnostic testing procedures, ] [ cardiovascular diagnosis and screening, diabetes monitoring and diagnosis, ] [ pregnancy monitoring, ] [ detecting, screening and monitoring infectious diseases, monitoring and diagnosing metabolic functions, diagnosing and monitoring inflammatory diseases, blood analysis, urine analysis, stool analysis, fecal analysis, saliva analysis, analysis of oral fluids, ] [ analysis of amniotic fluids, ] [ analysis of CSF (cervicospinalfluid), analysis of ascites, analysis of pleural fluids, analysis of exudate, analysis of cervical, vaginal and cervico-vaginal secretions, diagnosis of skin disorders, thyroid disease screening, screening for cancer; ] [ in-vitro diagnostic test kits for medical purposes for professional or home use comprised of collection pads or swabs, collection loops or vials, test strips capable of visual or instrument read out of test results and/or vials of developer solution or reagents, which use ] [ oral fluid, urine, feces, ] [ amniotic fluid, vaginal secretions, cervical secretions, cervico-vaginal secretions, ] [ finger stick or venipuncture whole blood, plasma, serum, exudate, skin, CSF (cervicospinalfluid), ascites, pleural fluids, ] [ and other bodily fluids and specimens for use in detecting ] [ antibodies, ] [ antigen ] [ , viruses, bacteria and other pathogens, disease markers and metabolites, fecal occult blood, hormones, vitamins, proteins, nucleic acids, toxins, drugs and their metabolites, drugs of abuse and chemicals ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oy Medix Biochemica Ab
- Other trademarks owned by Oy Medix Biochemica Ab
- Other trademarks owned by Oy Medix Biochemica Ab
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named MEDIX BIOCHEMICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 14, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Apr 9, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 24, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 24, 2026 | INPC | INVALIDATION PROCESSED | — |
| Oct 19, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 3, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 15, 2025 | PRAN | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED | — |
| Feb 3, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 3, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jan 28, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 25, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Sep 2, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jun 15, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 24, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 29, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 29, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 26, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 23, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Sep 2, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 16, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 2, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 27, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 12, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 12, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 2, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 2, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 17, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 28, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 15, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 5, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 2, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 2, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 2, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2013 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 12, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 7, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 7, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 7, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 6, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 1, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |